article thumbnail

EvoNexus Rolls Out New Tech Incubator Class

socalTECH

San Diego-based nonprofit EvoNexus has launched a new class of companies to its startup incubator, the group said on Tuesday, for both its San Diego and Irvine locations. According to EvoNexus, it has added 16 new companies to its portfolio of startups, split between both locations.

Incubator 124
article thumbnail

TuSimple Prices IPO, Starts Trading Today

socalTECH

San Diego-based TuSimple priced its IPO last night, saying that it will sell 33,783,783 shares of its Class A common stock at the price of $40.00 Morgan, along withBofA Securities, Cowen, Credit Suisse, Nomura and RBC Capital Markets, Baird, Needham & Company, Oppenheimer & Co., Piper Sandler and Valuable Capital.

Pricing 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hone Gets $16M For Corporate Training

socalTECH

San Diego-based Hone, a provider of a corporate learning platform, has raised $16M in a Series A funding round. The funding was F-Prime Capital and also included Cowboy Ventures, NextGen Venture Partners, Slack Fund, Gaingels, Swift Ventures, and SemperVirens. Hone is led by CEO Tom Griffiths.

Training 100
article thumbnail

Cardiff Oncology Raises $13.5M

socalTECH

San Diego-based Cardiff Oncology said this morning that it has raised $13.5M The company, which is working on drugs to treat cancer, said the funding was led by Acorn Bioventures and CAM Capital. in an equity funding round. The company is led by CEO Dr. Mark Erlander. READ MORE>>.

San Diego 113
article thumbnail

VelosBio Finds $137M For Oncology Efforts

socalTECH

San Diego-based biopharmaceuticals developer VelosBio says it has raised $137M in a Series B funding roudn, to go towards its oncology efforts. Venrock Healthcare Capital Partners, Viking Global Investors, Wellington Management Company, as well as the company's existing investors. Rowe Price Associates, Inc., READ MORE>>.

San Diego 113
article thumbnail

Ensysce Biosciences Names New CFO, COO

socalTECH

San Diego-based Ensysce Biosciences , a clinical phase, drug development company aiming at overcoming prescription drug abuse and overdose issues, said it has named a new CFO and COO this morning. The startup says it is working on a new class of analgesic which will curb prescription drug abuse and overdose. READ MORE>>.

San Diego 113
article thumbnail

The top 10 cities for $100M VC rounds in 2018 so far

TechCrunch LA

Jason Rowley is a venture capital and technology reporter for Crunchbase News. In this case, it’s mostly just the SF Bay Area, plus others scattered between Boston, Los Angeles, San Diego and one ( Magic Leap ) in the unfortunately named Plantation, Florida. Jason Rowley. Contributor. More posts by this contributor.